trimethoprim has been researched along with Leukemia in 51 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 63 neutropenic patients receiving cytotoxic therapy for acute leukemia were randomly allocated to receive norfloxacin (400 mg every 12 hours) or cotrimoxazole (160/800 mg every 12 hours) to prevent bacterial infection." | 9.06 | Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis. ( Bow, EJ; Louie, TJ; Rayner, E, 1988) |
| "Ciprofloxacin, a new quinolone derivative, was given prophylactically (500 mg twice daily) to 15 patients with acute leukemia during remission induction treatment." | 9.06 | Ciprofloxacin for infection prevention in patients with acute leukemia. ( Dekker, AW; Rozenberg-Arska, M, 1987) |
| "Fifty-six patients receiving remission induction treatment for acute leukemia were studied in a randomized trial comparing ciprofloxacin with trimethoprim-sulfamethoxazole plus colistin for prevention of infections." | 9.06 | Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. ( Dekker, AW; Rozenberg-Arska, M; Verhoef, J, 1987) |
| "In a comparative study of infection prophylaxis, patients with acute leukemia receiving remission induction therapy were assigned either no prophylaxis, sulfamethoxazole and trimethoprim, ketoconazole, or the combination of sulfamethoxazole and trimethoprim and ketoconazole." | 9.05 | Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two. ( Bodey, GP; Estey, E; Fainstein, V; Freireich, EJ; Keating, M; Maksymiuk, A; McCredie, KB; Smith, T, 1984) |
| "The efficacy of orally administered trimethoprim/sulfamethoxazole for infection prevention following induction chemotherapy was evaluated in 43 patients with acute leukemia." | 9.05 | Oral trimethoprim/sulfamethoxazole in attempt to prevent infection after induction chemotherapy for acute leukemia. ( Arlin, Z; Armstrong, D; Clarkson, B; Gee, T; Henry, SA; Kempin, S, 1984) |
| "Fifty-three profoundly granulocytopenic patients with relapsed acute leukemia who were undergoing reinduction chemotherapy were prospectively randomized to receive either trimethoprim-sulfamethoxazole plus nystatin or gentamicin plus nystatin for prevention of infections." | 9.05 | A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. ( Fortner, CL; Hargadon, MT; Schimpff, SC; Wade, JC; Wiernik, PH; Young, VM, 1981) |
| "Fifty-two patients with nonlymphocytic leukaemia were studied during remission induction treatment in a randomized trial to ascertain the effect of prophylactic oral trimethoprim-sulfamethoxazole on infection and fever rate." | 9.05 | Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia. ( Dekker, AW; Rozenberg-Arska, M; Sixma, JJ; Verhoef, J, 1981) |
| "We conducted a prospective, controlled, randomized trial of oral trimethoprim-sulfamethoxazole treatment in patients with acute leukemia receiving consolidation chemotherapy." | 9.05 | Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: a controlled trial. ( Armstrong, D; Fialk, MA; Lange, M; Singer, C; Szatrowski, TH; Weiser, B, 1981) |
| "The amikacin-carbenicillin-cotrimoxazole combination was used as an empiric treatment for febrile episodes in patients with acute leukemia and severe granulocytopenia." | 7.66 | Empiric treatment of infections in granulocytopenic patients with acute leukemia: a study on amikacin-carbenicillin-cotrimoxazole. ( Cortelezzi, A; Penagini, R; Pogliani, EM; Radaelli, F, 1982) |
| "A combination of sulfamethoxazole and trimethoprim was given orally to 13 children with acute leukemia on 16 occasions of hospitalization during remission induction chemotherapy for the prophylaxis of bacterial infection." | 7.66 | Prophylaxis of bacterial infection by sulfamethoxazole-trimethoprim (SMX-TMP) during chemotherapy in patients with childhood acute leukemia. ( Matsumoto, S; Nakajima, T; Nakayama, M; Ohkawa, M; Takeda, T; Tono-oka, T, 1981) |
| "A total of 63 neutropenic patients receiving cytotoxic therapy for acute leukemia were randomly allocated to receive norfloxacin (400 mg every 12 hours) or cotrimoxazole (160/800 mg every 12 hours) to prevent bacterial infection." | 5.06 | Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis. ( Bow, EJ; Louie, TJ; Rayner, E, 1988) |
| "Ciprofloxacin, a new quinolone derivative, was given prophylactically (500 mg twice daily) to 15 patients with acute leukemia during remission induction treatment." | 5.06 | Ciprofloxacin for infection prevention in patients with acute leukemia. ( Dekker, AW; Rozenberg-Arska, M, 1987) |
| "Fifty-six patients receiving remission induction treatment for acute leukemia were studied in a randomized trial comparing ciprofloxacin with trimethoprim-sulfamethoxazole plus colistin for prevention of infections." | 5.06 | Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. ( Dekker, AW; Rozenberg-Arska, M; Verhoef, J, 1987) |
| "Patients with acute nonlymphocytic leukemia were randomized to receive remission induction therapy consisting of seven days of cytosine arabinoside and three days of daunorubicin ("7 + 3") or to receive the same regimen intensified by either the addition of 6-thioguanine or by extension of the administration of cytosine arabinoside to ten days." | 5.06 | Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B study. ( Carey, R; Davis, RB; Dupre, E; Hoagland, HC; Kirshner, J; Kopel, S; Levy, RN; Preisler, H; Richards, F; Schulman, P, 1987) |
| "In a comparative study of infection prophylaxis, patients with acute leukemia receiving remission induction therapy were assigned either no prophylaxis, sulfamethoxazole and trimethoprim, ketoconazole, or the combination of sulfamethoxazole and trimethoprim and ketoconazole." | 5.05 | Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two. ( Bodey, GP; Estey, E; Fainstein, V; Freireich, EJ; Keating, M; Maksymiuk, A; McCredie, KB; Smith, T, 1984) |
| "43 patients undergoing treatment for acute leukaemia were randomised to receive either co-trimoxazole alone or co-trimoxazole with framycetin and colistin as antibacterial prophylaxis during periods of neutropenia." | 5.05 | Co-trimoxazole alone for prevention of bacterial infection in patients with acute leukaemia. ( Catovsky, D; Darrell, J; Donnelly, P; Galton, DA; Goldman, JM; Johnson, SA; Starke, ID, 1982) |
| "In an attempt to reduce the incidence of fever and infection, we randomized patients with cancer to receive trimethoprim/sulfamethoxazole plus erythromycin (TMP/SMX + E) versus placebos after each cycle of chemotherapy (no crossover) and to continue until granulocytopenia (polymorphonuclear leukocytes less than 500/mm3) resolved or the patient became febrile." | 5.05 | Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial. ( Edwards, BK; Johnson, A; Kramer, BS; Pizzo, PA; Robichaud, KJ; Schumaker, C, 1983) |
| "Of 545 patients expected to develop prolonged neutropenia and randomized to received trimethoprim-sulfamethoxazole (TMP-SMZ) or placebo, 342 were evaluable for occurrence of infection or bacteremia." | 5.05 | Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group. ( , 1984) |
| "The efficacy of orally administered trimethoprim/sulfamethoxazole for infection prevention following induction chemotherapy was evaluated in 43 patients with acute leukemia." | 5.05 | Oral trimethoprim/sulfamethoxazole in attempt to prevent infection after induction chemotherapy for acute leukemia. ( Arlin, Z; Armstrong, D; Clarkson, B; Gee, T; Henry, SA; Kempin, S, 1984) |
| "Fifty-three profoundly granulocytopenic patients with relapsed acute leukemia who were undergoing reinduction chemotherapy were prospectively randomized to receive either trimethoprim-sulfamethoxazole plus nystatin or gentamicin plus nystatin for prevention of infections." | 5.05 | A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. ( Fortner, CL; Hargadon, MT; Schimpff, SC; Wade, JC; Wiernik, PH; Young, VM, 1981) |
| "Fifty-two patients with nonlymphocytic leukaemia were studied during remission induction treatment in a randomized trial to ascertain the effect of prophylactic oral trimethoprim-sulfamethoxazole on infection and fever rate." | 5.05 | Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia. ( Dekker, AW; Rozenberg-Arska, M; Sixma, JJ; Verhoef, J, 1981) |
| "Sixty-two profoundly granulocytopenic patients with acute leukemia undergoing induction chemotherapy were prospectively randomized to receive either trimethoprim-sulfamethoxazole plus nystatin or nalidixic acid plus nystatin for prevention of infection." | 5.05 | Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid. ( Crowley, J; de Jongh, CA; Newman, KA; Schimpff, SC; Wade, JC; Wiernik, PH, 1983) |
| "We conducted a prospective, controlled, randomized trial of oral trimethoprim-sulfamethoxazole treatment in patients with acute leukemia receiving consolidation chemotherapy." | 5.05 | Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: a controlled trial. ( Armstrong, D; Fialk, MA; Lange, M; Singer, C; Szatrowski, TH; Weiser, B, 1981) |
| "Spurious methotrexate (MTX) concentrations in sera and cerebrospinal fluids from leukemia patients who were given trimethoprim (TMP) were estimated using an MTX assay kit which is based on its inhibition of dihydrofolate reductase." | 3.67 | Trimethoprim interference in methotrexate assay by an enzyme inhibition assay kit. ( Goto, E; Kitaoka, S; Konno, T; Miyaji, T; Terasawa, M; Tsuchiya, S, 1986) |
| "The amikacin-carbenicillin-cotrimoxazole combination was used as an empiric treatment for febrile episodes in patients with acute leukemia and severe granulocytopenia." | 3.66 | Empiric treatment of infections in granulocytopenic patients with acute leukemia: a study on amikacin-carbenicillin-cotrimoxazole. ( Cortelezzi, A; Penagini, R; Pogliani, EM; Radaelli, F, 1982) |
| "A combination of sulfamethoxazole and trimethoprim was given orally to 13 children with acute leukemia on 16 occasions of hospitalization during remission induction chemotherapy for the prophylaxis of bacterial infection." | 3.66 | Prophylaxis of bacterial infection by sulfamethoxazole-trimethoprim (SMX-TMP) during chemotherapy in patients with childhood acute leukemia. ( Matsumoto, S; Nakajima, T; Nakayama, M; Ohkawa, M; Takeda, T; Tono-oka, T, 1981) |
| "Norfloxacin has been compared to placebo (136 patients), sulfamethoxazole plus trimethoprim (SXT, 72 patients) and oral vancomycin plus colistin (V/C, 61 patients) for the prevention of alimentary tract-associated infections during and after induction chemotherapy." | 2.66 | The tolerability profile of prophylactic norfloxacin in neutropenic patients. ( Corrado, ML; Hesney, M; Struble, WE, 1988) |
| "Treatment of drug-induced aplastic anemia requires transfusions." | 2.35 | Drug-induced anaemias. ( Girdwood, RH, 1976) |
| "In patients with AIDS a more indolent illness occurred lasting 3 or more weeks and was characterised by fever, dry cough and breathlessness." | 1.27 | Management of Pneumocystis carinii pneumonia in the immunocompromised host. ( Carter, JM; Fisher, M; Holloway, L; Jones, MR; McSweeney, P; Town, GI, 1988) |
| "Between 1976 and 1983, 53 cases of Pneumocystis carinii pneumonia were documented at the Mayo Clinic." | 1.27 | Pneumocystis carinii pneumonia. Review of 53 cases. ( Peters, SG; Prakash, UB, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 49 (96.08) | 18.7374 |
| 1990's | 2 (3.92) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Estey, E | 1 |
| Maksymiuk, A | 1 |
| Smith, T | 1 |
| Fainstein, V | 1 |
| Keating, M | 1 |
| McCredie, KB | 1 |
| Freireich, EJ | 1 |
| Bodey, GP | 1 |
| Starke, ID | 1 |
| Donnelly, P | 1 |
| Catovsky, D | 1 |
| Darrell, J | 1 |
| Johnson, SA | 1 |
| Goldman, JM | 1 |
| Galton, DA | 1 |
| Hargadon, MT | 2 |
| Young, VM | 2 |
| Schimpff, SC | 3 |
| Wade, JC | 3 |
| Minah, GE | 1 |
| Pizzo, PA | 1 |
| Robichaud, KJ | 1 |
| Edwards, BK | 1 |
| Schumaker, C | 1 |
| Kramer, BS | 1 |
| Johnson, A | 1 |
| Riben, PD | 1 |
| Louie, TJ | 2 |
| Lank, BA | 2 |
| Kornachuk, E | 1 |
| Gurwith, MJ | 2 |
| Harding, GK | 2 |
| Ronald, AR | 2 |
| Winston, DJ | 1 |
| Ho, WG | 1 |
| Champlin, RE | 1 |
| Gale, RP | 1 |
| Henry, SA | 2 |
| Siegel, SE | 1 |
| Wolff, LJ | 2 |
| Baehner, RL | 1 |
| Hammond, D | 1 |
| Inoue, M | 1 |
| Arai, S | 1 |
| Kamiya, H | 1 |
| Sakurai, M | 1 |
| Izawa, T | 1 |
| Yamakawa, T | 1 |
| Kamiya, K | 1 |
| Nishimura, Y | 1 |
| Kato, T | 1 |
| Hiratani, Y | 1 |
| Akatuka, J | 1 |
| Hirotu, T | 1 |
| Armstrong, D | 2 |
| Kempin, S | 1 |
| Gee, T | 1 |
| Arlin, Z | 1 |
| Clarkson, B | 1 |
| Imoke, E | 1 |
| Dudgeon, DL | 1 |
| Colombani, P | 1 |
| Leventhal, B | 1 |
| Buck, JR | 1 |
| Haller, JA | 1 |
| Fortner, CL | 1 |
| Wiernik, PH | 2 |
| Dekker, AW | 3 |
| Rozenberg-Arska, M | 4 |
| Sixma, JJ | 1 |
| Verhoef, J | 3 |
| Mozzana, R | 1 |
| Cortelezzi, A | 2 |
| Radaelli, F | 2 |
| Polli, EE | 1 |
| Scaglione, C | 1 |
| Tormena, AM | 1 |
| Pavlovsky, S | 1 |
| de Jongh, CA | 1 |
| Newman, KA | 1 |
| Crowley, J | 1 |
| Beutler, SM | 1 |
| Barth, NM | 1 |
| Bayer, AS | 1 |
| Penagini, R | 1 |
| Pogliani, EM | 1 |
| Weiser, B | 1 |
| Lange, M | 1 |
| Fialk, MA | 1 |
| Singer, C | 1 |
| Szatrowski, TH | 1 |
| Kersey, JH | 1 |
| Ramsay, NK | 1 |
| Kim, T | 1 |
| McGlave, P | 1 |
| Krivit, W | 1 |
| Levitt, S | 1 |
| Filipovich, A | 1 |
| Woods, W | 1 |
| O'Leary, M | 1 |
| Coccia, P | 1 |
| Nesbit, ME | 1 |
| Wilson, JM | 1 |
| Guiney, DG | 1 |
| Jacoby, GA | 1 |
| Young, LS | 1 |
| Tono-oka, T | 1 |
| Nakayama, M | 1 |
| Ohkawa, M | 1 |
| Nakajima, T | 1 |
| Takeda, T | 1 |
| Matsumoto, S | 1 |
| Ward, TT | 1 |
| Thomas, RG | 1 |
| Fye, CL | 1 |
| Arbeit, R | 1 |
| Coltman, CA | 1 |
| Craig, W | 1 |
| Dana, BW | 1 |
| Finegold, SM | 1 |
| Lentino, J | 1 |
| Penn, RL | 1 |
| Guiot, HF | 1 |
| van der Meer, JW | 1 |
| van Furth, R | 1 |
| Kunz, HD | 1 |
| Brunton, JL | 1 |
| Ezaki, K | 1 |
| Ohno, R | 1 |
| Kamiya, T | 1 |
| Kawashima, K | 1 |
| Kodera, Y | 1 |
| Ogata, K | 1 |
| Kobayashi, M | 1 |
| Takeyama, H | 1 |
| Morishima, Y | 1 |
| Kato, Y | 1 |
| Watanabe, E | 1 |
| Suzuki, H | 1 |
| Tanimoto, M | 1 |
| Yamada, K | 1 |
| Minami, S | 1 |
| Sako, F | 1 |
| Imamura, K | 1 |
| Gurwith, M | 1 |
| Girdwood, RH | 1 |
| Melikian, V | 1 |
| Falk, R | 1 |
| Tuan, IZ | 1 |
| Dennison, D | 1 |
| Weisdorf, DJ | 1 |
| Günther, I | 1 |
| Kaben, U | 1 |
| Dunker, H | 1 |
| Brijmohan-Günther, R | 1 |
| Konrad, H | 1 |
| Verhagen, C | 2 |
| Stalpers, LJ | 1 |
| de Pauw, BE | 2 |
| Haanen, C | 1 |
| Dekker, A | 2 |
| Gaus, W | 1 |
| Kurrle, E | 1 |
| de Vries-Hospers, H | 1 |
| van der Waaij, D | 1 |
| Wendt, F | 1 |
| Novakova, IR | 1 |
| Ubachs, E | 1 |
| Hoes, A | 1 |
| Stalpers, L | 1 |
| Carter, JM | 1 |
| Town, GI | 1 |
| Fisher, M | 1 |
| Holloway, L | 1 |
| Jones, MR | 1 |
| McSweeney, P | 1 |
| Corrado, ML | 1 |
| Struble, WE | 1 |
| Hesney, M | 1 |
| Bow, EJ | 1 |
| Rayner, E | 1 |
| Peters, SG | 1 |
| Prakash, UB | 1 |
| Rossi, MR | 1 |
| Banfi, P | 1 |
| Cappuccilli, M | 1 |
| Conter, V | 1 |
| de Poli, D | 1 |
| Piacentini, G | 1 |
| Zurlo, MG | 1 |
| Masera, G | 1 |
| Preisler, H | 1 |
| Davis, RB | 1 |
| Kirshner, J | 1 |
| Dupre, E | 1 |
| Richards, F | 1 |
| Hoagland, HC | 1 |
| Kopel, S | 1 |
| Levy, RN | 1 |
| Carey, R | 1 |
| Schulman, P | 1 |
| Kitaoka, S | 1 |
| Terasawa, M | 1 |
| Goto, E | 1 |
| Miyaji, T | 1 |
| Tsuchiya, S | 1 |
| Konno, T | 1 |
| Magyar, T | 1 |
| Graber, H | 1 |
| Arr, M | 1 |
| Csiba, A | 1 |
| Kelemen, E | 1 |
| Péterfy, M | 1 |
| Jánossa, M | 1 |
4 reviews available for trimethoprim and Leukemia
| Article | Year |
|---|---|
Infectious complications of bone marrow transplantation.
Topics: Aminoglycosides; Amphotericin B; Anemia, Aplastic; Bacterial Infections; Bone Marrow Transplantation | 1984 |
Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients.
Topics: Acute Disease; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topi | 1984 |
Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. Use of prophylactic antibiotics.
Topics: Adolescent; Adult; Amphotericin B; Anti-Bacterial Agents; Bacterial Infections; Candidiasis; Child; | 1984 |
Drug-induced anaemias.
Topics: Anemia; Anemia, Aplastic; Anemia, Megaloblastic; Anemia, Sideroblastic; Anticonvulsants; Bone Marrow | 1976 |
25 trials available for trimethoprim and Leukemia
| Article | Year |
|---|---|
Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two.
Topics: Acute Disease; Adolescent; Adult; Aged; Bacterial Infections; Drug Combinations; Drug Therapy, Combi | 1984 |
Co-trimoxazole alone for prevention of bacterial infection in patients with acute leukaemia.
Topics: Acute Disease; Adult; Aged; Bacterial Infections; Clinical Trials as Topic; Colistin; Drug Combinati | 1982 |
Selective suppression of alimentary tract microbial flora as prophylaxis during granulocytopenia.
Topics: Agranulocytosis; Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Carcinoma, Small Cell; D | 1981 |
Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial.
Topics: Adolescent; Adult; Agranulocytosis; Bacterial Infections; Child; Child, Preschool; Clinical Trials a | 1983 |
Reduction in mortality from gram-negative sepsis in neutropenic patients receiving trimethoprim/sulfamethoxazole therapy.
Topics: Adult; Aged; Agranulocytosis; Bacterial Infections; Clinical Trials as Topic; Female; Humans; Leukem | 1983 |
Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients.
Topics: Acute Disease; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topi | 1984 |
Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group.
Topics: Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Drug Combina | 1984 |
Treatment of Pneumocystis carinii pneumonitis. A comparative trial of sulfamethoxazole-trimethoprim v pentamidine in pediatric patients with cancer: report from the Children's Cancer Study Group.
Topics: Acute Disease; Adolescent; Adult; Amidines; Child; Child, Preschool; Clinical Trials as Topic; Drug | 1984 |
[The prophylactic effect of trimethoprim-sulfamethoxazole against infection among children with acute leukemia].
Topics: Acute Disease; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Combinat | 1983 |
Oral trimethoprim/sulfamethoxazole in attempt to prevent infection after induction chemotherapy for acute leukemia.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Antineoplastic Agents; Drug Combinations; Dr | 1984 |
A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; | 1981 |
Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia.
Topics: Acute Disease; Agranulocytosis; Amphotericin B; Drug Combinations; Drug Therapy, Combination; Fever; | 1981 |
[Prophylactic controlled trials with cotrimoxazole in afebrile neutropenic patients with malignant hemopathies].
Topics: Adult; Agranulocytosis; Child; Clinical Trials as Topic; Drug Combinations; Fever; Humans; Infection | 1982 |
Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Bacterial Infections; Child; Drug Combinations; Female; Hu | 1983 |
Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: a controlled trial.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Clinical Trials as Topic; D | 1981 |
Trimethoprim-sulfamethoxazole prophylaxis in granulocytopenic patients with acute leukemia: evaluation of serum antibiotic levels in a randomized, double-blind, placebo-controlled Department of Veterans Affairs Cooperative Study.
Topics: Acute Disease; Adult; Agranulocytosis; Bacterial Infections; Double-Blind Method; Female; Humans; Le | 1993 |
Infection prevention in acute leukaemia.
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Clinical Trials as Topic; Cross Infectio | 1978 |
A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacteriological Tech | 1979 |
Prevention of infection in patients with acute nonlymphocytic leukemia by several drug treatment regimens.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Clinical Trials as Topic; Colistin; Drug | 1987 |
The tolerability profile of prophylactic norfloxacin in neutropenic patients.
Topics: Agranulocytosis; Bacterial Infections; Clinical Trials as Topic; Colistin; Diarrhea; Gastrointestina | 1988 |
Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis.
Topics: Acute Disease; Adult; Antineoplastic Agents; Bacterial Infections; Clinical Trials as Topic; Drug Co | 1988 |
Ciprofloxacin for infection prevention in patients with acute leukemia.
Topics: Adult; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Colistin; Drug Combinations; D | 1987 |
Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.
Topics: Acute Disease; Agranulocytosis; Bacterial Infections; Ciprofloxacin; Colistin; Drug Combinations; Dr | 1987 |
Prospective randomized comparison of two prophylactic regimens with trimethoprim-sulfamethoxazole in leukemic children: a two year study.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; | 1987 |
Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B study.
Topics: Acute Disease; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Administration Schedule; Dru | 1987 |
23 other studies available for trimethoprim and Leukemia
| Article | Year |
|---|---|
Open lung biopsy in the immunocompromised pediatric patient.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Drug Combinations; Female; Humans; Immunosuppression Th | 1983 |
Efficacy of the tobramycin - cotrimoxazole - cephalothin combination for febrile episodes in leukemic patients with granulocytopenia.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Cephalothin; Child; Drug Combinatio | 1981 |
Preventing infection in neutropenic cancer patients.
Topics: Agranulocytosis; Bacterial Infections; Humans; Immunosuppression Therapy; Leukemia; Neutropenia; Sul | 1983 |
Empiric treatment of infections in granulocytopenic patients with acute leukemia: a study on amikacin-carbenicillin-cotrimoxazole.
Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial | 1982 |
Allogeneic bone marrow transplantation in acute nonlymphocytic leukemia: a pilot study.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclophosphamide; Female; Graf | 1982 |
Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia: isolation of resistant plasmids from strains of Enterobacteriaceae causing bacteremia.
Topics: Acute Disease; Adult; Agranulocytosis; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterobact | 1982 |
Perils of prophylaxis.
Topics: Agranulocytosis; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Mi | 1982 |
Trimethoprim-Sulfamethoxazole and bacterial infections during leukemia therapy.
Topics: Bacterial Infections; Drug Therapy, Combination; Humans; Leukemia; Sulfamethoxazole; Trimethoprim | 1981 |
Prophylaxis of bacterial infection by sulfamethoxazole-trimethoprim (SMX-TMP) during chemotherapy in patients with childhood acute leukemia.
Topics: Acute Disease; Adolescent; Antineoplastic Agents; Bacterial Infections; Child; Child, Preschool; Dru | 1981 |
Prophylactic co-trimoxazole in leukaemia.
Topics: Acute Disease; Anti-Bacterial Agents; Cross Infection; Drug Combinations; Drug Evaluation; Drug Ther | 1978 |
[Allergic-toxic agranulocytosis].
Topics: Abscess; Agranulocytosis; Diagnosis, Differential; Drug Hypersensitivity; Female; Humans; Leukemia; | 1979 |
[Treatment of infection in the patients of acute leukemia with sulfamethoxazole-trimethoprim (author's transl)].
Topics: Acute Disease; Adolescent; Adult; Aged; Drug Combinations; Drug Synergism; Enterobacteriaceae Infect | 1979 |
Prevention of infection in leukaemia.
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Combinations; Humans; Leukemia; Sulfamethoxazole; | 1978 |
Treatment of febrile episodes in neutropenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Clindamycin; Drug Combinations; Fever; Humans; Immunosuppres | 1976 |
Pneumocystis carinii pneumonitis following bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Drug Combinations; Female; Humans; Infant; Le | 1992 |
Selective decontamination of the digestive tract and fungal infection in acute leukemia patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Bacterial Infections; Digestive System; Drug Administration | 1988 |
Drug-induced skin reactions in patients with acute non-lymphocytic leukaemia.
Topics: Acute Disease; Adult; Allopurinol; Cephalosporins; Drug Combinations; Drug Eruptions; Female; Humans | 1987 |
Selective decontamination of the digestive tract for the prevention of infection in acute leukemia.
Topics: Acute Disease; Amphotericin B; Bacterial Infections; Digestive System; Drug Combinations; Humans; Le | 1985 |
Co-trimoxazole in patients with haematological malignancies: a review of 10-years' clinical experience.
Topics: Anti-Infective Agents; Drug Combinations; Humans; Intestines; Leukemia; Neutropenia; Opportunistic I | 1988 |
Management of Pneumocystis carinii pneumonia in the immunocompromised host.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Drug Combinations; Female; Humans; Immu | 1988 |
Pneumocystis carinii pneumonia. Review of 53 cases.
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; Drug Combinations; Female; Humans; Leuk | 1987 |
Trimethoprim interference in methotrexate assay by an enzyme inhibition assay kit.
Topics: Diagnostic Errors; Folic Acid Antagonists; Humans; Leukemia; Methotrexate; Reagent Kits, Diagnostic; | 1986 |
[Treatment of infections in granulocytopenia patients with a brulamycin-bactrim combination].
Topics: Adult; Aged; Agranulocytosis; Bacterial Infections; Drug Combinations; Drug Therapy, Combination; Fe | 1985 |